The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
Advertisement
The Nutshell
Daily News Roundup
Most Recent
Proposals from researchers receiving more than $1 million a year in NIH funding will be carefully picked over to avoid overlap with ongoing research.
The rise in the amount of federal money requested through research grants is due to a rise in the overall number of applicants.
Charles Nemeroff, who was barred from receiving grants for 2 years in 2008, snags $401K from the NIH to study PTSD.
Opponents of a new law requiring government researchers to publicly disclose personal financial information claim it is an invasion of privacy.
The head of a US infectious disease funding body urges researchers to continue the voluntary cessation of research on avian influenza.
A postdoctoral research fellow at Emory University falsifies stem cell research data.
The United Kingdom's Wellcome Trust announces that it will begin sanctioning researchers who do not submit manuscripts to the public UK PubMed Central database.
An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.
The Senate approves an increase of about 0.3 percent for the 2013 NIH budget, but the Department of Energy doesn’t fare as well.
Subjects
- cancer
- cell & molecular biology
- culture
- disease/medicine
- ecology
- evolution
- funding
- genetics & genomics
- NIH
- policy
Sub Categories
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
